FULGENT GENETICS INC (FLGT) Stock Price, Quote, News and Overview
NASDAQ:FLGT - Nasdaq - US3596641098 - Common Stock - Currency: USD
FLGT Quote, Performance and Key Statistics
21.74
-0.03 (-0.14%)
The current stock price of FLGT is 21.74 USD. In the past month the price increased by 19.91%. In the past year, price decreased by -7.41%.
FLGT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.53 | 84.41B | ||
| CI | THE CIGNA GROUP | 10.34 | 77.56B | ||
| LH | LABCORP HOLDINGS INC | 17.92 | 22.49B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.86 | 19.95B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.19 | 14.59B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 106.38 | 13.89B | ||
| HIMS | HIMS & HERS HEALTH INC | 58.91 | 10.55B | ||
| DVA | DAVITA INC | 13.87 | 10.15B | ||
| GH | GUARDANT HEALTH INC | N/A | 7.48B | ||
| CHE | CHEMED CORP | 19.84 | 6.49B | ||
| RDNT | RADNET INC | 190.97 | 5.29B | ||
| OPCH | OPTION CARE HEALTH INC | 21.04 | 4.65B |
Related stock screener links
About FLGT
Company Profile
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. The company is headquartered in El Monte, California and currently employs 1,313 full-time employees. The company went IPO on 2016-09-28. Its laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. Its testing services include comprehensive anatomic pathology testing services, including gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology, and precision diagnostics testing services, including next-generation sequencing (NGS), tests for biopharma research and clinical tests for rare disease, hereditary cancer, reproductive health, and many other diseases.
Company Info
FULGENT GENETICS INC
4399 Santa Anita Ave
El Monte CALIFORNIA 91780 US
CEO: Ming Hsieh
Employees: 1313
Phone: 16263500537
FULGENT GENETICS INC / FLGT FAQ
What is the stock price of FULGENT GENETICS INC today?
The current stock price of FLGT is 21.74 USD. The price decreased by -0.14% in the last trading session.
What is the ticker symbol for FULGENT GENETICS INC stock?
The exchange symbol of FULGENT GENETICS INC is FLGT and it is listed on the Nasdaq exchange.
On which exchange is FLGT stock listed?
FLGT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for FULGENT GENETICS INC stock?
9 analysts have analysed FLGT and the average price target is 22.44 USD. This implies a price increase of 3.22% is expected in the next year compared to the current price of 21.74. Check the FULGENT GENETICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is FULGENT GENETICS INC worth?
FULGENT GENETICS INC (FLGT) has a market capitalization of 661.77M USD. This makes FLGT a Small Cap stock.
How many employees does FULGENT GENETICS INC have?
FULGENT GENETICS INC (FLGT) currently has 1313 employees.
What are the support and resistance levels for FULGENT GENETICS INC (FLGT) stock?
FULGENT GENETICS INC (FLGT) has a support level at 21.73 and a resistance level at 21.75. Check the full technical report for a detailed analysis of FLGT support and resistance levels.
Is FULGENT GENETICS INC (FLGT) expected to grow?
The Revenue of FULGENT GENETICS INC (FLGT) is expected to grow by 9.64% in the next year. Check the estimates tab for more information on the FLGT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy FULGENT GENETICS INC (FLGT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of FLGT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of FLGT, evaluating the profitability, health, valuation and growth aspects
- FULGENT GENETICS INC (FLGT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- FULGENT GENETICS INC (FLGT) Sales and EPS estimates to see what analysts future expectations are.
- FULGENT GENETICS INC (FLGT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- FULGENT GENETICS INC (FLGT) Insider and Institutional Ownership to learn about the owners and their transactions.
- FULGENT GENETICS INC (FLGT) Stock Chart to make your own analysis
- FULGENT GENETICS INC (FLGT) Latest news and press-releases to stay up to date.
Does FULGENT GENETICS INC (FLGT) stock pay dividends?
FLGT does not pay a dividend.
When does FULGENT GENETICS INC (FLGT) report earnings?
FULGENT GENETICS INC (FLGT) will report earnings on 2025-11-06, before the market open.
What is the Price/Earnings (PE) ratio of FULGENT GENETICS INC (FLGT)?
The PE ratio for FULGENT GENETICS INC (FLGT) is 47.26. This is based on the reported non-GAAP earnings per share of 0.46 and the current share price of 21.74 USD. Check the full fundamental report for a full analysis of the valuation metrics for FLGT.
What is the Short Interest ratio of FULGENT GENETICS INC (FLGT) stock?
The outstanding short interest for FULGENT GENETICS INC (FLGT) is 9.19% of its float. Check the ownership tab for more information on the FLGT short interest.
FLGT Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to FLGT. When comparing the yearly performance of all stocks, FLGT is a bad performer in the overall market: 66.08% of all stocks are doing better.
FLGT Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to FLGT. The financial health of FLGT is average, but there are quite some concerns on its profitability.
FLGT Financial Highlights
Over the last trailing twelve months FLGT reported a non-GAAP Earnings per Share(EPS) of 0.46. The EPS increased by 1433.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.25% | ||
| ROE | -4.57% | ||
| Debt/Equity | 0 |
FLGT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to FLGT. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -214.49% and a revenue growth 9.64% for FLGT